Verb Technology Company, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND SUPPLEMENTAL DISCLOSURES (Details Narrative)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND SUPPLEMENTAL DISCLOSURES (Details Narrative) - USD ($)					3 Months Ended			9 Months Ended		12 Months Ended
	Nov. 07, 2022	Oct. 25, 2022	Apr. 20, 2022	Jan. 12, 2022	Sep. 30, 2022	Sep. 30, 2021	Jun. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021	Sep. 29, 2022
Product Information [Line Items]
Net loss					$ 8,028,000	$ 8,805,000		$ 21,391,000	$ 28,962,000
Net cash used in operating activities								$ 15,975,000	20,511,000
Common stock, par value					$ 0.0001			$ 0.0001		$ 0.0001
Repayments of Debt								$ 5,381,000	$ 7,162,000
Cash and Cash Equivalents, at Carrying Value					$ 921,000			921,000		$ 937,000
Employee Retention Credit provisions						$ 1,500	$ 1,500
FDIC Insured Amount					$ 250,000			250,000
Reclassification of cash								$ 2,288,000
Revenue Benchmark [Member] \| Customer Concentration Risk [Member] \| One Customer [Member]
Product Information [Line Items]
Concentration risk, percentage					11.00%
Revenue Benchmark [Member] \| Customer Concentration Risk [Member] \| No Customer [Member]
Product Information [Line Items]
Concentration risk, percentage						10.00%		10.00%	10.00%
Accounts Receivable [Member] \| Customer Concentration Risk [Member] \| No Customer [Member]
Product Information [Line Items]
Concentration risk, percentage								10.00%		10.00%
Accounts Payable [Member] \| Supplier Concentration Risk [Member] \| Vendor One [Member]
Product Information [Line Items]
Concentration risk, percentage					54.00%	17.00%		45.00%	31.00%
Accounts Payable [Member] \| Supplier Concentration Risk [Member] \| Vendor Two [Member]
Product Information [Line Items]
Concentration risk, percentage					11.00%	16.00%		16.00%	20.00%
Accounts Payable [Member] \| Supplier Concentration Risk [Member] \| One Vendor [Member]
Product Information [Line Items]
Concentration risk, percentage								42.00%		40.00%
Purchase [Member] \| Supplier Concentration Risk [Member] \| Two Vendors [Member]
Product Information [Line Items]
Concentration risk, percentage					65.00%	48.00%		61.00%	36.00%
Share-Based Payment Arrangement, Option [Member]
Product Information [Line Items]
Antidilutive securities								5,252,119	5,528,405
Warrant [Member]
Product Information [Line Items]
Antidilutive securities								25,651,407	11,008,302
Restricted Stock [Member]
Product Information [Line Items]
Antidilutive securities								2,071,849	2,109,999
Convertible Notes Due 2023 [Member]
Product Information [Line Items]
Debt converted instrument, amount								$ 1,209,610	$ 0
Debt converted instrument, price per share					$ 3.00	$ 3.00		$ 3.00	$ 3.00
Subsequent Event [Member] \| Convertible Notes Due 2023 [Member]
Product Information [Line Items]
Debt Instrument, Periodic Payment		$ 1,172,000
Debt Instrument, Periodic Payment, Principal		$ 2,545,000
Related Party [Member]
Product Information [Line Items]
Debt converted instrument, amount								$ 808,900	$ 742,278
Debt converted instrument, price per share					$ 1.03	$ 1.03		$ 1.03	$ 1.03
U.S. Small Business Administration [Member]
Product Information [Line Items]
Loan payable											$ 350,000
Common Stock Purchase Agreement [Member] \| Tumim Stone Capital LLC [Member]
Product Information [Line Items]
Common stock, par value				$ 0.0001
Shares issued, shares				607,287
Common Stock Purchase Agreement [Member] \| Tumim Stone Capital LLC [Member] \| Maximum [Member]
Product Information [Line Items]
Shares issued, value				$ 50,000,000
January Note Purchase Agreement [Member] \| Three Institutional Investors [Member]
Product Information [Line Items]
Debt original principal amount				$ 6,300,000
Securities Purchase Agreement [Member]
Product Information [Line Items]
Shares issued, shares			14,666,667
Warrants purchase			14,666,667
Warrant exercise price per share			$ 0.75
Proceeds from issuance of warrants			$ 11,000,000
Repayments of Debt			$ 1,650,000
Securities Purchase Agreement [Member] \| Subsequent Event [Member]
Product Information [Line Items]
Shares issued, shares		12,500,000
Warrants purchase		12,500,000
Warrant exercise price per share		$ 0.75
Proceeds from issuance of warrants		$ 4,000,000
Increase decrease warrant exercise price per share		$ 0.34
Share Price		$ 0.32
Securities Purchase Agreement [Member] \| Series A Warrants [Member]
Product Information [Line Items]
Increase decrease warrant exercise price per share			$ 0.75
Securities Purchase Agreement [Member] \| Maximum [Member] \| Series A Warrants [Member]
Product Information [Line Items]
Warrant exercise price per share			2.10
Securities Purchase Agreement [Member] \| Minimum [Member] \| Series A Warrants [Member]
Product Information [Line Items]
Warrant exercise price per share			$ 1.10
November Note Purchase Agreement [Member] \| Subsequent Event [Member] \| November Note Holder [Member]
Product Information [Line Items]
Debt original principal amount	$ 5,470
Original issue discount	470
Debt gross proceeds	$ 5,000
Debt instrument, description	The November Note matures eighteen months following the date of issuance. Commencing six months from the date of issuance, the Company is required to make monthly cash redemption payments in an amount not to exceed $600. The November Note may be repaid in whole or in part prior to the maturity date for a 10% premium. The November Note requires the Company to use 20% of the gross proceeds raised from future equity or debt financings, or the sale of any subsidiary or material asset, to prepay the November Note, subject to a cap on the aggregate prepayment amount.